National Tire Safety Week is an industry-wide initiative that educates drivers about the importance of proper tire care. Summer is the season for road trips, so now is a good time to brush up on your tire maintenance knowledge. Remember though, tire safety is critical all year round.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7127551-michelin-tire-rack-street-survival-announces-national-program-schedule
The Walt Disney Studios today unveiled its exclusive cloud-based digital movie service, Disney Movies Anywhere. This all-new app for iPhone, iPad, and iPod touch and Web experience enables consumers to discover, purchase, manage, and watch movies from Disney, Pixar, and Marvel at home and on the go. iTunes is the premier digital movie provider for Disney Movies Anywhere.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65907-disney-app-watch-disney-pixar-and-marvel-with-movies-anywhere-itunes
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
After years of analyzing attempted abductions, the National Center for Missing & Exploited Children® has identified the tricks used by abductors, and the most successful escape strategies for children. NCMEC and Honeywell (NYSE:HON) are working together to deliver this insight nationwide through KidSmartz™, the premier abduction prevention program that equips teachers and parents with tools to help protect children.
A key component of the program is the KidSmartz “Safety Dance” Video Contest. From January through March, elementary schools were asked to submit videos of their students dancing to the new KidSmartz “Safety Dance,” a reimagining of a popular 1980’s song with new lyrics designed to give kids the knowledge and confidence to avoid abduction.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7521451-ncmec-honeywell-safety-dance/
blu, the brand which pioneered electronic vaping, will launch a new global brand and marketing campaign, under the tagline “Just You & blu.”
The campaign celebrates the individualistic lifestyles of blu consumers – each representing an independent spirit, carving their own paths in life and enjoying blu along the way. The “Just You & blu” campaign will feature television and cinema commercials, print ads and billboards, as well as digital and social content. “Just You & blu” will premier April 4 in the United States, United Kingdom, Italy and France.
blu has been the innovator in electronic vaping since the brand was introduced in 2009, and continues to evolve as the ultimate consumer vaping experience.
“blu is the most iconic brand in the electronic vaping category,” said John Wardley, Chief Marketing Officer for Fontem Ventures, blu’s parent company. “This campaign will serve to solidify and grow the leadership position blu enjoys in the US and the UK, while introducing the brand to new consumers in our two launch markets, Italy and France.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7801651-just-you-and-blu/
MIRANDA ®, a premier supplier for the bicycle industry, has announced today the launch of their revolutionary INFINIUM™ crankset, introducing their ChainFLOW™ technology, with its unconventional tooth profile, to the market.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7384751-miranda-infinium-bicycle-crankset/
On Saturday May 30th at the French Tennis Open, the Beijing Municipal Commission of Tourism Development unveiled its first tourism package, “Enjoy the China Open, Visit Beijing”, or how to combine sport and visits to the cultural sites of Beijing. This comprehensive package includes three days of guided visits to the city’s most beautiful tourist sites, as well as three days to experience the China Open, featuring the world’s top players. With a host of options, the package will meet the needs of sports fans and cultural travel enthusiasts alike.
This exclusive package comprises a joint offer by the Beijing Municipal Commission of Tourism Development and the China Open. It will include several visits to key tourist attractions in the city, such as Tiananmen Square, the Forbidden City and even the Great Wall of China. At the same time, travellers will also be able to take advantage of 3 days courtside, at the China Open, a WTA premier mandatory event and an ATP 500 event, which is the biggest international competition in Asia.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7535351-visit-beijing-tourism-china-open/
Lowe Boats is a Premier manufacturer of Aluminum Fishing Boats, Small Pontoon Boats, Fish & Ski Boats, Deck Boats, Jon Boats, Panfish, Crappie & Utility Boats. Get the Specifications, reviews and ratings for various Models of Lowe Boats for Fishing or Sports Boats, Bass Boats & Deck Pontoon Boats. For more information visit http://www.loweboats.com
Quinny and Maxi-Cosi, premier European brands owned by Dorel Juvenile, a segment of Dorel Industries (TSX: DII.B, DII.A), and the world's largest juvenile products manufacturer in its categories, today announced the arrival of the Rachel Zoe x Quinny and Maxi-Cosi Collection, a luxurious collection of strollers, car seats and baby gear designed by Rachel Zoe. The collection, now available for purchase at Nordstrom, followed by retailers globally later this year, retails in the US from $229 to $899 and includes the Quinny® Moodd stroller, the Maxi-Cosi® Mico Max 30 and Maxi-Cosi® Pria 85 car seats, and Quinny Diaper Bag.
With nearly two decades of experience in design and fashion, Zoe has become a household name, embodying modern, effortless glamour and timeless sophistication. From designing her eponymous ready-to-wear, jewelry, and footwear collection and authoring two New York Times bestselling books, to serving as Editor-in-Chief of digital lifestyle destination The Zoe Report, Rachel’s influence reaches millions daily and continues to grow. As a mother of two young boys, Zoe’s influence also extends from fashion, beauty and style into the worlds of parenthood, home, entertaining and lifestyle.
To view the multimedia release go to:
http://www.multivu.com/players/English/7851951-dorel-juvenile-rachel-zoe-nordstrom/
The Thailand Convention and Exhibition Bureau has unveiled 'Thailand CONNECT', a global marketing campaign designed to make it easier for corporate buyers and meetings organisers to sell Thailand as a premier MICE destination.
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
